The device is a proprietary, low cost, non-invasive, radiation-free tool that uses military grade thermal cameras to measure heat/vascular patterns which are indicative of breast cancer. The test is painless and takes about 10 minutes.
The device will be used by OB/GYNs and Internists as part of an annual physical exam, as well as by oncologists to monitor patients subsequent to cancer diagnosis/treatment. It’s projected sensitivity is 95% vs. a clinical breast exam by the doctor at 45% (mammogram at 75%. The device and software automate a manual process that has been perfected as a result of testing 1,000,000+ women over the past 40+ years. The company has an exclusive worldwide license to this methodology that has been validated in a 2,000 woman clinical trial. The company has an experienced management team. Board is anchored by the co-developer of Lipitor, Roger Newton, PhD.
Company has potential to provide significant return to investors and save thousands of lives.